Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05550298 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv31
  2. Study sites: 26 to 27v30
  3. Lead sponsor: St. Jude Children's Research Hospital to Arkansas Children's Hospital Research Institute Collaborators: 1 to 4v29 Show 1 more changeShow less
    • Collaborators: 1 to 4

    See this version in full on ClinicalTrials.gov ↗

  4. Study sites: 25 to 26v28
  5. Study sites: 24 to 25v27
Show 25 earlier versionsHide 25 earlier versions
  1. Study sites: 23 to 24v26
  2. Study sites: 22 to 23v25
  3. Study sites: 21 to 22v24
  4. Study sites: 20 to 21v23
  5. Study sites: 19 to 20v22
  6. Study sites: 18 to 19v21
  7. Study sites: 17 to 18v20
  8. Re-verified, no change to tracked fieldsv19
  9. Study sites: 16 to 17v18
  10. Study sites: 14 to 16v17
  11. Study sites: 13 to 14v16
  12. Study sites: 12 to 13v15
  13. Study description expanded, about 7 wordsv14 See this version in full on ClinicalTrials.gov ↗
  14. Study sites: 11 to 12v13
  15. Study sites: 9 to 11v12
  16. Study sites: 7 to 9v11
  17. Study sites: 6 to 7v10
  18. Study sites: 5 to 6v9
  19. Study sites: 4 to 5v8
  20. Eligibility criteria expanded, about 1 wordv7 See this version in full on ClinicalTrials.gov ↗
  21. Start date changed from estimate of Dec 2022 to Dec 13, 2022v6
  22. Study sites: 2 to 4v5
  23. Start date: Nov 2022 to Dec 2022v4
  24. Trial status: Not Yet Recruiting to Recruiting Start date: Oct 2022 to Nov 2022 · Site details revised at 2 of 2 sitesv3 Show 2 more changesShow less
    • Start date: Oct 2022 to Nov 2022
    • Site details revised at 2 of 2 sites
  25. Study sites: 1 to 2v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The participants are being asked to take part in this clinical trial, a type of research study, because the participants are scheduled to receive or have recently received a hematopoietic cell transplant (HCT) or a solid organ transplant (SOT). Primary Objective To determine if pre-transplant screening for respiratory viral load predicts RVI within 1- year post-transplant among survivors. Secondary Objectives: * To develop and validate a classifier based on pre-transplant immunological profile predictive of developing an acute respiratory viral infection (aRVI), with RSV/PIV3/HMPV/SARS-CoV-2 through one-year post-transplant among survivors. * To develop and validate a classifier based on Day +100 post-transplant immunological profiles predictive of developing an acute respiratory viral infection (aRVI),with RSV/PIV3/HMPV/SARS-CoV-2 through one-year post-transplant among survivors .
Trial Details
NCT Number NCT05550298
Lead Sponsor Arkansas Children's Hospital Research Institute
Collaborators: St. Jude Children's Research Hospital, Seattle Children's Hospital, Children's Hospital at Montefiore, National Institute of Allergy and Infectious Diseases (NIAID)
Conditions Hematopoietic Cell Transplant, Solid Organ Transplant, Respiratory Viral Infection
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov